These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21067271)

  • 61. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
    Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
    Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
    Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenetic upregulation of spleen tyrosine kinase in cancer cells through p53-dependent downregulation of DNA methyltransferase.
    Huang DY; Lu ST; Chen YS; Cheng CY; Lin WW
    Exp Cell Res; 2023 Apr; 425(2):113540. PubMed ID: 36889573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
    Blancato J; Graves A; Rashidi B; Moroni M; Tchobe L; Ozdemirli M; Kallakury B; Makambi KH; Marian C; Mueller SC
    PLoS One; 2014; 9(2):e87610. PubMed ID: 24523870
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 68. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
    Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.
    Duta F; Ulanova M; Seidel D; Puttagunta L; Musat-Marcu S; Harrod KS; Schreiber AD; Steinhoff U; Befus AD
    Histochem Cell Biol; 2006 Oct; 126(4):495-505. PubMed ID: 16708245
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 73. PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer.
    Li J; Qi L; Zhang M; Yao C; Feng J; Zheng Z; Chen C; Duan S; Qi Y
    Zhongguo Fei Ai Za Zhi; 2022 Feb; 25(2):78-85. PubMed ID: 35224960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Study of the expression and function of Syk and VEGF-C in the development of non-small cell lung cancer].
    Guo JZ; Sun QF; Cong B; Zhao YP; Peng CL; Zhao XG
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(47):3801-3. PubMed ID: 24548403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
    Inayat U; Kayani MA; Faryal R
    Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers.
    Yano M; Toyooka S; Tsukuda K; Dote H; Ouchida M; Hanabata T; Aoe M; Date H; Gazdar AF; Shimizu N
    Int J Cancer; 2005 Jan; 113(1):59-66. PubMed ID: 15386433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
    Li Z; Cai Z; Tao B; Jin Q
    Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.